Schering AG files patent infringement lawsuit against Barr Laboratories, Inc. and Barr Pharmaceuticals, Inc.

03-May-2005

Schering AG, Germany announced that it has, along with its affiliate, Berlex, Inc., filed a patent infringement action against Barr Laboratories, Inc. and its parent company Barr Pharmaceuticals, Inc. relating to Schering AG's Yasmin® (drospirenone and ethinyl estradiol) product.

Yasmin® is the subject of an Abbreviated New Drug Application. Barr Laboratories, Inc. is currently seeking approval from the United States Food and Drug Administration to produce and market a generic version of Yasmin®.

The patent infringement lawsuit by Schering AG and Berlex, Inc. was filed in the United States District Court for the District of New Jersey.

Other news from the department research and development

Most read news

More news from our other portals

Discover the latest developments in battery technology!